These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 12134611)

  • 1. The epidemic of esophageal adenocarcinoma.
    el-Serag HB
    Gastroenterol Clin North Am; 2002 Jun; 31(2):421-40, viii. PubMed ID: 12134611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of Barrett's Esophagus and Esophageal Adenocarcinoma.
    Runge TM; Abrams JA; Shaheen NJ
    Gastroenterol Clin North Am; 2015 Jun; 44(2):203-31. PubMed ID: 26021191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laryngopharyngeal reflux symptoms better predict the presence of esophageal adenocarcinoma than typical gastroesophageal reflux symptoms.
    Reavis KM; Morris CD; Gopal DV; Hunter JG; Jobe BA
    Ann Surg; 2004 Jun; 239(6):849-56; discussion 856-8. PubMed ID: 15166964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Troublesome Epidemiology of Barrett's Esophagus and Esophageal Adenocarcinoma.
    Schneider JL; Corley DA
    Gastrointest Endosc Clin N Am; 2017 Jul; 27(3):353-364. PubMed ID: 28577761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of adenocarcinoma of the esophagus, gastric cardia, and upper gastric third.
    Vial M; Grande L; Pera M
    Recent Results Cancer Res; 2010; 182():1-17. PubMed ID: 20676867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of esophageal adenocarcinoma.
    Pera M; Manterola C; Vidal O; Grande L
    J Surg Oncol; 2005 Dec; 92(3):151-9. PubMed ID: 16299786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etiology of Barrett's metaplasia and esophageal adenocarcinoma.
    Kim R; Weissfeld JL; Reynolds JC; Kuller LH
    Cancer Epidemiol Biomarkers Prev; 1997 May; 6(5):369-77. PubMed ID: 9149898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between diabetes and esophageal cancer, independent of obesity, in the United States Veterans Affairs population.
    Dixon JL; Copeland LA; Zeber JE; MacCarthy AA; Reznik SI; Smythe WR; Rascoe PA
    Dis Esophagus; 2016 Oct; 29(7):747-751. PubMed ID: 26455587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence of Barrett's esophagus in the US: estimates from a simulation model confirmed by SEER data.
    Hayeck TJ; Kong CY; Spechler SJ; Gazelle GS; Hur C
    Dis Esophagus; 2010 Aug; 23(6):451-7. PubMed ID: 20353441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barrett's esophagus and risk of esophageal adenocarcinoma.
    Cossentino MJ; Wong RK
    Semin Gastrointest Dis; 2003 Jul; 14(3):128-35. PubMed ID: 14653412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helicobacter pylori Infection Is Associated With Reduced Risk of Barrett's Esophagus: An Analysis of the Barrett's and Esophageal Adenocarcinoma Consortium.
    Wang Z; Shaheen NJ; Whiteman DC; Anderson LA; Vaughan TL; Corley DA; El-Serag HB; Rubenstein JH; Thrift AP
    Am J Gastroenterol; 2018 Aug; 113(8):1148-1155. PubMed ID: 29880962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Present Status and Future of Barrett's Esophageal Adenocarcinoma in Japan.
    Nishi T; Makuuchi H; Ozawa S; Shimada H; Chino O
    Digestion; 2019; 99(2):185-190. PubMed ID: 30481763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in incidence and prevalence of specialized intestinal metaplasia, barrett's esophagus, and adenocarcinoma of the gastroesophageal junction.
    Pera M
    World J Surg; 2003 Sep; 27(9):999-1008; discussion 1006-8. PubMed ID: 12917764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receipt of previous diagnoses and endoscopy and outcome from esophageal adenocarcinoma: a population-based study with temporal trends.
    Cooper GS; Kou TD; Chak A
    Am J Gastroenterol; 2009 Jun; 104(6):1356-62. PubMed ID: 19491849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of risk for Barrett's esophagus and esophageal adenocarcinoma.
    Thrift AP
    Curr Opin Gastroenterol; 2016 Jul; 32(4):319-24. PubMed ID: 27276368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening and surveillance for complications related to gastroesophageal reflux disease.
    Spechler SJ
    Am J Med; 2001 Dec; 111 Suppl 8A():130S-136S. PubMed ID: 11749938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of upper gastrointestinal malignancies.
    Crew KD; Neugut AI
    Semin Oncol; 2004 Aug; 31(4):450-64. PubMed ID: 15297938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Adenocarcinoma of the esophagogastric junction: association with Barrett esophagus and gastroesophageal reflux--surgical results in 122 patients].
    Schumpelick V; Dreuw B; Ophoff K; Fass J
    Leber Magen Darm; 1996 Mar; 26(2):75-6, 79-80, 83-6. PubMed ID: 8684248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett's esophagus, Barrett's dysplasia, and Barrett's adenocarcinoma.
    Weston AP; Badr AS; Topalovski M; Cherian R; Dixon A; Hassanein RS
    Am J Gastroenterol; 2000 Feb; 95(2):387-94. PubMed ID: 10685740
    [